Showing results (171-180 of 31,421) with videos related to

Sort By:
Pageof 3,143
Antimicrobial Agents and Chemotherapy|November 16, 2001
Binding properties of a peptide derived from beta-lactamase inhibitory proteinG W Rudgers, W Huang, T Palzkill
Antimicrobial Agents and Chemotherapy|November 16, 2001
Functional expression of Candida albicans drug efflux pump Cdr1p in a Saccharomyces cerevisiae strain deficient in membrane transportersK Nakamura, M Niimi, K Niimi, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2001
Intrinsic resistance of Mycobacterium smegmatis to fluoroquinolones may be influenced by new pentapeptide protein MfpAC Montero, G Mateu, R Rodriguez, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2001
Ritonavir-saquinavir dual protease inhibitor compared to ritonavir alone in human immunodeficiency virus-infected patientsC Michelet, A Ruffault, V Sébille, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2001
MDR1-mediated drug resistance in Candida dubliniensisS Wirsching, G P Moran, D J Sullivan, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2001
Staphylococcus aureus mutants isolated via exposure to nonfluorinated quinolones: detection of known and unique mutationsS Roychoudhury, T L Twinem, K M Makin, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2001
Papillomavirus microbicidal activities of high-molecular-weight cellulose sulfate, dextran sulfate, and polystyrene sulfonateN D Christensen, C A Reed, T D Culp, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2001
P-113D, an antimicrobial peptide active against Pseudomonas aeruginosa, retains activity in the presence of sputum from cystic fibrosis patientsU S Sajjan, L T Tran, N Sole, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2001
Safety, tolerance, and pharmacokinetics of high-dose liposomal amphotericin B (AmBisome) in patients infected with Aspergillus species and other filamentous fungi: maximum tolerated dose studyT J Walsh, J L Goodman, P Pappas, et al.
Antimicrobial Agents and Chemotherapy|November 16, 2001
Prevalence and mechanisms of macrolide resistance in invasive and noninvasive group B streptococcus isolates from Ontario, CanadaJ C de Azavedo, M McGavin, C Duncan, et al.
Pageof 3,143